Han Ying

This study is testing if adding the steroid prednisone to the standard liver disease drug UDCA works better for people with a specific form of primary biliary cholangitis (PBC). It focuses on patients whose liver biopsies show moderate-to-severe inflammation, a group that often d…

This study tested whether adding fenofibrate to the standard treatment (ursodeoxycholic acid) helps people with primary biliary cholangitis, a chronic liver disease. Researchers measured whether the combination improves liver blood tests and reduces symptoms like itching and fati…